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Limiting the spread of COVID-19 in Africa : one size mitigation 
strategies do not fit all countries
On March 11, 2020, when coronavirus disease 2019 
(COVID-19), caused by severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), was declared a 
pandemic by WHO, there were comparatively few cases 
reported from Africa.1 Our Comment draws on early 
imported COVID-19 cases in South Africa, Senegal, 
Democratic Republic of the Congo, and Egypt as case 
studies to discuss important mitigation strategies of 
COVID-19 in Africa.
Early COVID-19 cases in Africa were mostly imported 
from Europe, due to the higher volume of business and 
tourism airline traffic between African countries and 
Europe, and less from China.2 The first confirmed case 
was reported in Egypt on Feb 14, 2020, (an adult male 
whose 17 contacts tested negative) and prompted 
African preparedness efforts.3,4 In South Africa, on 
Feb 29, 2020, a group of nine adult travellers returned 
from a skiing holiday in Italy, where the COVID-19 
epidemic was rampant. After developing a flu-like 
illness, one traveller tested positive  for COVID-19, which 
was confirmed by RT-PCR on March 5, 2020; his wife was 
asymptomatic but tested positive on March 8, 2020. 
Overall, seven of the nine travellers were positive for 
COVID-19, five of whom were asymptomatic. In Senegal, 
the first COVID-19 case was reported on March 7, 2020, 
in a traveller returning from Italy. Contact tracing 
identified a cluster of transmission of 20 cases within 
his immediate household. Democratic Republic of 
the Congo confirmed its first case of COVID-19 on 
March 10, 2020: an adult male who tested positive in 
the capital city of Kinshasa after developing a cough and 
fever, 2 days after returning from France. These early 
index cases show the imported nature of the epidemic 
in Africa among young affluent adult travellers from 
Europe. However, the majority of COVID-19 cases 
currently being identified and reported from African 
countries are due to local transmission.
Early estimates of case fatality rates (CFRs) also seem 
to vary substantially. As of April 24, 2020, South Africa 
had reported 3635 cases with 65 deaths (CFR 1·8%) 
and Senegal had reported 442 cases with 6 deaths 
(CFR 1·3%). These CFRs seem lower than in most 
European countries (eg, Italy had reported 187 327 cases 
with 25 085 deaths; CFR 13·4%). Since mortality rates 
are generally higher in older people, it could be assumed 
that a younger African population distribution will 
lessen the death rate of COVID-19 on the continent.4 
However, it is too early to predict the death rate as 
Africa is at the ascending phase of the epidemic curve. 
Furthermore, the high prevalence of HIV, tuberculosis, 
hypertension, and diabetes, coupled with weak health-
care systems in Africa, might lead to high mortality 
rates among comorbid populations. Indeed, Egypt 
(3659 cases with 276 deaths; CFR 7·5%) and Democratic 
Republic of the Congo (359 cases with 25 deaths; 
CFR 6·9%) have reported much higher CFRs than South 
Africa and Senegal.
Since the emergence of COVID-19 on the continent, 
African governments have had to decide whether, in 
addition to following WHO recommendations to test 
widely, contact trace, and quarantine,5 they would 
adopt draconian measures such as total lockdowns, 
stay at home to save lives campaigns, and travel 
and movement restrictions as has been done in 
European and Asian countries.5 Physical distancing and 
handwashing, globally adopted interventions to combat 
the spread of COVID-19, remain a major challenge 
in the context of overcrowding, poverty, and weak 
health-care systems.6 A combination model of country-
specific economic estimates of the benefits of disease 
avoidance and epidemiological projections of the spread 
of COVID-19 raises several possible issues.7 First, the 
benefits of physical distancing could be substantially 
smaller in low-income countries due to the smaller 
proportions of older people and because, although 
physical distancing and lockdowns flatten the epidemic 
curve and reduce pressure on health systems, this effect 
is less apparent in countries with already overwhelmed 
and weak health-care systems. Second, the economic 
value in terms of lives saved by physical distancing 
policies is likely to be much higher in high-income 
countries than countries in which these policies have 
more detrimental effects on incomes. Although physical 
distancing slows the transmission of the virus, it exacts 
a heavy toll on the informal economic and casual labour 
sector. In search of income for the day-to-day livelihood 
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of extended families, many Africans could be forced to 
ignore concerns about contracting COVID-19 and fend 
for their survival.
Furthermore, the effect of ongoing lockdowns (eg, 
partial in Senegal and Democratic Republic of the Congo 
vs total in South Africa) and case-finding mitigation 
strategies will depend on each country’s political 
leadership, socioeconomic realities, and epidemic 
stage. Early evidence of flattening the epidemic curve 
through a proactive, 30-day total lockdown and 
physical distancing is being documented in South 
Africa. However, before physical distancing measures 
can be eased, it is crucial to have in place a robust and 
functioning public health infrastructure to scale up case 
finding through testing, isolation, and contact tracing 
to ultimately interrupt coronavirus transmission. To 
reduce the rate of infections, the South African National 
Health Laboratory Service is planning to administer 
36 000 RT-PCR-based tests per day by the end of April 
and more than 28 000 trained community health-
workers will be sent house-to-house in susceptible 
communities for screening, testing, and contact tracing 
using mobile phone technology assisted by Médecins 
Sans Frontières.8 Notably, point-of-care RT-PCR-based 
Xpert Xpress SARS-CoV-2 testing with a fast turnaround 
(45 min) using small GeneXpert machines (Cepheid, 
Sunnyvale, CA, USA), ideal for mass community 
testing, will be available in South Africa by the end of 
April, 2020.9
As COVID-19 spreads across Africa, causing disruption 
of already fragile health systems, it is becoming clear 
that responses require action beyond the health sector 
and must be tailored to the local situation. Lacking 
governmental financial support, as is being provided for 
populations and businesses in Europe and USA, most of 
Africa’s poorest citizens will ignore quarantine directives 
and continue to engage in communal activities to 
earn incomes for their families. Some countries must 
also provide for other vulnerable populations such 
as migrants, stateless people, and forcibly displaced 
refugees. As larger datasets are generated by increasing 
case numbers in Africa and while vaccines are awaited, 
factors which underlie asymptomatic or milder clinical 
presentations and any differences of mortality or 
severe disease between geographical  regions of 
Africa need to be investigated further to find local 
solutions.10 Possible factors include innate immune 
mechanisms, HLA types, effects of the BCG vaccination, 
cross-protective immunity due to repeated infections 
with other coronavirus species that cause mild upper 
respiratory tract infections or locally prevalent parasitic 
infections. These factors could ultimately provide clues 
to the development of preventive and therapeutic 
interventions for COVID-19 relevant to Africa and 
beyond.
In conclusion, while African leaders ponder COVID-19 
mitigation strategies to reduce risks of transmission 
versus the deprivation and hunger that will result from 
prolonged economic disruption, the quest for solutions 
must continue. Some countries are investing in low-cost 
preventive measures to improve physical distancing, 
such as stopping international travel, reducing the 
number of people at religious and social gatherings, 
and universal masking using non-medical cloth masks 
for the community. Other measures could focus on 
protecting older people, allowing individuals restricted 
working hours for income generation, information 
campaigns for personal hygiene, physical distancing, 
and handwashing. As lockdowns and physical distancing 
measures are eased, proactive surveillance, case 
detection, and contact tracing with isolation will be 
required to prevent a dramatic resurgence of COVID-19 
cases.
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